Risk of malignancy in patients with rheumatoid arthritis, psoriatic arthritis and ankylosing spondylitis under immunosuppressive therapy: a single-center experience

2015 ◽  
Vol 11 (1) ◽  
pp. 31-40 ◽  
Author(s):  
Marta Fantò ◽  
Mario Stefano Peragallo ◽  
Mario Pietrosanti ◽  
Roberta Di Rosa ◽  
Andrea Picchianti Diamanti ◽  
...  
Keyword(s):  
Rheumatoid Arthritis ◽  
Psoriatic Arthritis ◽  
Ankylosing Spondylitis ◽  
Immunosuppressive Therapy ◽  
Single Center ◽  
Single Center Experience ◽  
Risk Of Malignancy

Comparison of continuation rates with three TNFα antagonists (adalimumab, infliximab, etanercept) in rheumatoid arthritis, ankylosing spondylitis, and psoriatic arthritis: Retrospective 10-year study

2016 ◽  
Vol 83 (5) ◽  
pp. 607-609 ◽  
Author(s):  
Benjamin Batteux ◽  
Agathe Devauchelle ◽  
Pauline Lasselin Boyard ◽  
Alice Sejourné ◽  
Patrice Fardellone ◽  
...  
Keyword(s):  
Rheumatoid Arthritis ◽  
Psoriatic Arthritis ◽  
Ankylosing Spondylitis ◽  
Continuation Rates
Sign in / Sign up

Export Citation Format

Share Document